Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells

Thiel, U; Schober, SJ; Einspieler, I; Kirschner, A; Thiede, M; Schirmer, D; Gall, K; Blaeschke, F; Schmidt, O; Jabar, S; Ranft, A; Rubio, RA; Dirksen, U; Grunewald, TGP; Sorensen, PH; Richter, GHS; von Luttichau, IT; Busch, DH; Burdach, SEG

Burdach, SEG (reprint author), Tech Univ Munich, Klinikum Rechts Isar, Kinderklin Munchen Schwabing, Dept Pediat, D-81644 Munich, Germany.; Burdach, SEG (reprint author), Tech Univ Munich, Klinikum Rechts Isar, Kinderklin Munchen Schwabing, Pediat Oncol C

ONCOIMMUNOLOGY, 2017; 6 (5):

Abstract

Background: Chondromodulin-I (CHM1) sustains malignancy in Ewing sarcoma (ES). Refractory ES carries a dismal prognosis and patients with bone marrow ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索